These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 4749642)
1. Use of frozen cryoprecipitate for the preparation of clinical factor VIII concentrate. Sgouris JT; Wickerhauser M Transfusion; 1973; 13(6):399-404. PubMed ID: 4749642 [No Abstract] [Full Text] [Related]
2. Development of large-scale fractionation methods. 3. Preparation of a factor VIII concentrate of intermediate-purity. James HL; Wickerhauser M Vox Sang; 1972; 23(5):402-12. PubMed ID: 5077739 [No Abstract] [Full Text] [Related]
3. Levels of hepatitis B antigen and isoagglutinins in clinical concentrates of factor VIII and prothrombin complex. Wickerhauser M Dev Biol Stand; 1974; 27():172-7. PubMed ID: 4463121 [No Abstract] [Full Text] [Related]
4. Clotting factor activity in cryoprecipitates and supernatant plasma prepared from blood collected into ACD, ACD-adenine, CPD, and CPD-adenine and from plasma collected by plasmapheresis. Graybeal FQ; Mooreside DE; Langdell RD Transfusion; 1969; 9(3):135-40. PubMed ID: 5782206 [No Abstract] [Full Text] [Related]
5. Immunologic studies of antihemophilic factor (AHF, factor VIII). V. Immunologic properties of AHF subunits produced by salt dissociation. Rick ME; Hoyer LW Blood; 1973 Nov; 42(5):737-47. PubMed ID: 4200955 [No Abstract] [Full Text] [Related]
6. Factor VIII fractionation on aminohexyl Sepharose with possible reduction in hepatitis B antigen. Austen DE; Smith JK Thromb Haemost; 1982 Aug; 48(1):46-8. PubMed ID: 6813994 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B antigen and antibody in patients with systemic lupus erythematosus. Shorey J; Cheatum DE; Combes B; Ziff M Arthritis Rheum; 1974; 17(5):583-9. PubMed ID: 4413665 [No Abstract] [Full Text] [Related]
8. [Donor selection for the production of factor XIII preparations]. Uteg KH; Tausendfreund K Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):447-55. PubMed ID: 2414175 [TBL] [Abstract][Full Text] [Related]
9. [Development and characterization of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)]. Ristol P; Gensana M; Fernández J; Massot M; Bhattacharya P; Jorquera JI Sangre (Barc); 1996 Apr; 41(2):125-30. PubMed ID: 9045352 [TBL] [Abstract][Full Text] [Related]
10. Technical aspects and results of the determination of hepatitis associated antigen (HAA) and antibody. Brummelhuis HG Vox Sang; 1970; 19(3):228-33. PubMed ID: 4993776 [No Abstract] [Full Text] [Related]
11. Improved yields of factor VIII from heparinized plasma. Rock GA; Cruickshank WH; Tackaberry ES; Palmer DS Vox Sang; 1979; 36(5):294-300. PubMed ID: 462918 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in hemophilia. Part III. Discussion paper: The Red Cross program. Greenwalt TJ Ann N Y Acad Sci; 1975 Jan; 240():208-12. PubMed ID: 1053865 [No Abstract] [Full Text] [Related]
13. Cryoprecipitate. Armstrong D S Afr Med J; 1975 Jul; 49(31):1245-7. PubMed ID: 1154189 [No Abstract] [Full Text] [Related]
14. Implications of immunologic methods for measuring antihemophilic factor (factor VIII). Hoyer LW; Rick ME Ann N Y Acad Sci; 1975 Jan; 240():97-108. PubMed ID: 46140 [TBL] [Abstract][Full Text] [Related]
15. Utilization of the residual plasma following preparation of factor VIII cryoprecipitate. Oberman HA; Penner JA JAMA; 1968 Sep; 205(12):819-21. PubMed ID: 5695503 [No Abstract] [Full Text] [Related]
16. PEG test: a new radioimmunoassay for the detection of hepatitis B antigen. Lambert PH; Tribollet E; Knoepfel M; Madalinski K; Miescher PA Schweiz Med Wochenschr; 1974 Jan; 104(4):128-9. PubMed ID: 4855779 [No Abstract] [Full Text] [Related]
17. Preparation of antihemophilic factor from indated plasma. Wickerhauser M Transfusion; 1976; 16(4):345-50. PubMed ID: 951729 [TBL] [Abstract][Full Text] [Related]
18. Factor VIII collection by pheresis. McLeod BC; Sassetti RJ; Cole ER; Pierce MI Lancet; 1980 Sep; 2(8196):671-3. PubMed ID: 6106786 [TBL] [Abstract][Full Text] [Related]
19. A rapid screening method to increase efficiency in assaying plasma levels of clotting factor VIII:C inhibitors. White KS; Dombrose FA; Blatt PM Am J Clin Pathol; 1982 Oct; 78(4):450-6. PubMed ID: 6814233 [No Abstract] [Full Text] [Related]
20. Detection and measurement of low levels of prothrombin. Use of a procoagulant from Echis carinatus venom. Franza BR; Aronson DL Thromb Res; 1976 Mar; 8(3):329-36. PubMed ID: 1265706 [No Abstract] [Full Text] [Related] [Next] [New Search]